Welcome to BeOne
Medical Affairs

BeOne Medical Affairs is intended for health care professionals in the United States for the purpose of scientific exchange. This site contains educational resources and information relating to BeOne medicines, therapeutic areas of interest, congress materials, and publications. This site may include information on products or indications under investigation that are currently not approved in the United States. BeOne does not recommend the use of its products other than as described in the approved prescribing information. This site does not contain medical advice and does not replace independent medical judgment.

Please visit beonemedicines.us for more information.

I confirm that I am a US healthcare professional

Go to homepage

Skip to content

Sign up for updates

Congress Resources
Publications
Pipeline
Molecules
Clinical Trials

BGB-21447 (Next gen BCL2 inhibitor)

Molecule: BGB-21447

28 May 2025

Report an adverse Event

adverse_events@beonemed.com
Contact Us by Phone

Report a Product Complaint

productcomplaints@beonemed.com
Contact Us by Phone

Contact Us

beonemedicines.com/contact-us/
Contact Us by Phone

This website is intended for US Healthcare Professionals for scientific information exchange purposes only, not for advertising purposes, and does not constitute commercial promotion of any product or recommendation on diagnosis and treatments.
The website may contain information about products or indications that have not yet been approved in the US; for prescriptions, always refer to the approved product information, as well as, where applicable, the reimbursement conditions.
The safety and efficacy of investigational products or uses may not have been established. Because of the uncertainty of clinical trials, there is no guarantee that compounds will receive regulatory approval and become commercially available for the uses being investigated.